Interclean Shanghai

HealthTrio Partners with OptMyCare for Predictive Analytics

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

EU Begins Revision of Medical Device...

The European Commission has gone on to initiate a...

FDA Seeks Opinion on AI-Enabled Medical...

The U.S. Food and Drug Administration (US FDA) is...

FDA Approves Zenix Monitor-Defibrillator from ZOLL

ZOLL®, which happens to be an Asahi Kasei company...

MHRA in the UK Accelerates AI...

The Medicines and Healthcare Products Regulatory Agency (MHRA) from...

HealthTrio, an innovative Software-as-a-Service provider for health plans, third-party administrators, and other risk-bearing healthcare organizations, and OptMyCare, a healthcare predictive and descriptive analytics SaaS platform that provides risk stratification and mitigation outputs to risk-bearing entities, announced their partnership.

HealthTrio’s comprehensive digital engagement platform connecting members, providers and payers will now include OptMyCare’s unique analytics on risk stratification and mitigation pathways. This powerful combination will use data to identify patients who are at high risk for disease progression and will roll out actionable disease mitigation pathways to the patient. Health care technology leader and former CEO and Chairman of HMS (acquired by Gainwell technologies), Bill Lucia, commented that partnerships like these are essential for risk-bearing entities that do not have a highly accurate predictive solution. Moreover, it could take several years to develop an accurate predictive and prescriptive clinical risk solution.

“Incorporating OptMyCare’s solution into our platform will further increase the user experience and allow their providers and health plans to stay well informed on their members to provide the highest quality of care and cost savings,” said Jim Carlough, President of HealthTrio. “We are excited to see how this powerful product makes a difference for our clients.”

“This partnership would provide OptMyCare an opportunity to incorporate its machine learning risk stratification and prescriptive solution into HealthTrio’s workflow and learn from the real-time data feeds for maximizing prediction accuracies,” said Dr. Saravanan Bala, CEO of OptMyCare.

 

Latest stories

Related stories

EU Begins Revision of Medical Device Regulatory Framework

The European Commission has gone on to initiate a...

FDA Seeks Opinion on AI-Enabled Medical Devices Regulation

The U.S. Food and Drug Administration (US FDA) is...

FDA Approves Zenix Monitor-Defibrillator from ZOLL

ZOLL®, which happens to be an Asahi Kasei company...

MHRA in the UK Accelerates AI Rollout in the NHS

The Medicines and Healthcare Products Regulatory Agency (MHRA) from...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Translate »